The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury

• Andrea Ferrigno ,

  Contributed equally to this work with: Andrea Ferrigno, Laura Giuseppina Di Pasqua

  Roles Conceptualization, Formal analysis, Methodology, Writing – review & editing

  Affiliation Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy

  ⨯
• Laura Giuseppina Di Pasqua ,

  Contributed equally to this work with: Andrea Ferrigno, Laura Giuseppina Di Pasqua

  Roles Formal analysis, Methodology

  Affiliation Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy

  ⨯
• Clarissa Berardo,

  Roles Formal analysis, Methodology

  Affiliation Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy

  ⨯
• Veronica Siciliano,

  Roles Formal analysis, Methodology

  Affiliation Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy

  ⨯
• Vittoria Rizzo,

  Roles Formal analysis, Methodology

  Affiliation Department of Molecular Medicine, IRCCS San Matteo, University of Pavia, Pavia, Italy

  ⨯
• Luciano Adorini,

  Roles Writing – review & editing

  Affiliation Intercept Pharmaceuticals, San Diego, California, United States of America

  ⨯
• Plinio Richelmi,

  Roles Funding acquisition

  Affiliation Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy

  ⨯
• Mariapia Vairetti

  Roles Conceptualization, Writing – original draft, Writing – review & editing

  * E-mail: mariapia.vairetti@unipv.it

  Affiliation Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy

  http://orcid.org/0000-0002-2464-6127

  ⨯